Browsing: IBN

Oncotelic Therapeutics (OTCQB: OTLC), together with its wholly owned subsidiary Pet2DAO, Inc., announced that its PDAOAI artificial intelligence-powered drug discovery platform is inviting scientists, AI developers and biotech founders to participate in BIO REBOOT. Participants can bring research questions, technical

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing antiviral drugs, provided additional details on its Phase II clinical trial of NV-387 Oral Gummies for treatment of the current Bundibugyo Ebolavirus “BDBV” outbreak and other Ebola viruses in the Democratic

Silynxcom (NYSE American: SYNX), a manufacturer and developer of ruggedized tactical communication and hearing-protection devices, as well as other gear and accessories, recently announced that it received two consecutive purchase orders from a leading global defense company, totalling around $400,000

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising. 

Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce and engagement, announced a worldwide reseller agreement with Mastercard, authorizing Mastercard to market, offer and sell subscriptions to Rezolve Ai software and SaaS services worldwide on a non-exclusive basis. Mastercard

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. USA signed a two-year master maintenance and service agreement with BlockAssure Inc. to build, deploy and operate AssureChain, a dedicated subnet of MindChain for BlockAssure insurance and reinsurance operations.

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, received U.S. Food and Drug Administration “FDA” Breakthrough Device Designation for the HeartBeam System as a tool for assessing potential heart attacks at home. The designation recognizes the

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. 

Greenland Mines (NASDAQ: GRML; FSE: HK6), a Greenland-focused critical-minerals development company, exercised in full its option to acquire an additional 9.9% of AnorTech, increasing its ownership to 19.9%. Greenland Mines will acquire 25,168,669 AnorTech common shares at a deemed price

GlobalTech (OTCQB: GLTK) a U.S.-based technology platform company enabling growth in AI, data and frontier technologies, confirmed the composition of its Audit, Compensation and Nominating and Corporate Governance committees, along with the adoption of charters for each. The committees are